Stay updated on BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page.

Latest updates to the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov release/version change without altering the displayed study content.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded site Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E. 1 as a trial site on 2026-04-13. Removed Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E. on 2026-03-13; updated to Revision: v3.5.2.SummaryDifference0.1%

- Check17 days agoChange DetectedRemoved related-topic links for Multiple Myeloma and MedlinePlus Genetics from the study page.SummaryDifference0.1%

- Check39 days agoChange DetectedNew study sites added: Helsinki, Finland, 00290; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E.; Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E. The Helsinki site 00029 HUS and the generic Instituto Portugues de Oncologia affiliation were removed.SummaryDifference0.2%

- Check46 days agoChange DetectedDifference0.1%

- Check53 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' topic from the study's metadata. This changes the disease-related keywords associated with the page.SummaryDifference0.1%

Stay in the know with updates to BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page.